Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Public health implications of opening National Football League stadiums during the COVID-19 pandemic.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America; 4/5/2022, Vol. 119 Issue 14, p1-9, 9p
Abstract: Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright ho...
The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 8/23/2022, Vol. 119 Issue 34, p1-12. 33p.
Abstract: Antibody therapeutics for the treatment of COVID-19 have been highly successful. However, the recent emergence of the Omicron variant has posed a challenge, as it evades detection by most existing SARS-CoV-2 neutralizing antibodies (nAbs). Here, we suc...
Interferon resistance of emerging SARS-CoV-2 variants.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America; 8/9/2022, Vol. 119 Issue 32, p1-8, 26p
Abstract: Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright ho...
Correction.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 10/11/2022, Vol. 119 Issue 41, p1-2. 2p.
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 1/17/2023, Vol. 120 Issue 3, p1-12. 77p.
Abstract: SARS-CoV-2 vaccines are effective at limiting disease severity, but effectiveness is lower among patients with cancer or immunosuppression. Effectiveness wanes with time and varies by vaccine type. Moreover, previously prescribed vaccines were based on...
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 8/16/2022, Vol. 119 Issue 33, p1-12. 46p.
Abstract: With the rapid increase in SARS-CoV-2 cases in children, a safe and effective vaccine for this population is urgently needed. The MMR (measles/mumps/rubella) vaccine has been one of the safest and most effective human vaccines used in infants and child...
In situ architecture and membrane fusion of SARS-CoV-2 Delta variant.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 5/2/2023, Vol. 120 Issue 18, p1-20. 20p.
Abstract: Among the current five Variants of Concern, infections caused by SARS-CoV-2 B.1.617.2 (Delta) variant are often associated with the greatest severity. Despite recent advances on the molecular basis of elevated pathogenicity using recombinant proteins, ...
Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 4/18/2023, Vol. 120 Issue 16, Following p1-10. 16p.
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) possess mutations that confer resistance to neutralizing antibodies within the Spike protein and are associated with breakthrough infection and reinfection. By cont...
Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America. 3/28/2023, Vol. 120 Issue 13, Following p1-7. 13p.
Abstract: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) introduced a relatively large number of mutations, including three mutations in the highly conserved heptad repeat 1 (HR1) region of the spike glycoprotein (S) critical...
Three years of COVID-19 and life satisfaction in Europe: A macro view.
Publication Type: Academic Journal
Source(s): Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 May 09; Vol. 120 (19), pp. e2300717120. Date of Electronic Publication: 2023 May 01.
Abstract: Every country in Europe experienced an adverse impact from the COVID-19 pandemic on life satisfaction, though on average, satisfaction with life in the summer of 2022 is about the same as the pre-pandemic value in the autumn of 2019. Typically, an upsu...